000 01286 a2200349 4500
005 20250517155936.0
264 0 _c20190904
008 201909s 0 0 eng d
022 _a1989-4805
024 7 _a10.1016/j.hipert.2017.05.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKiuchi, M G
245 0 0 _aWhy is systolic blood pressure drop ≥10mmHg post RSD in patients with resistant hypertension considered responsiveness to the treatment? Should we interpret as science or arbitrariness?
_h[electronic resource]
260 _bHipertension y riesgo vascular
_c
300 _a42-43 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aAtrial Fibrillation
_xetiology
650 0 4 _aCatheter Ablation
650 0 4 _aCausality
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Resistance
650 0 4 _aHumans
650 0 4 _aHypertension
_xcomplications
650 0 4 _aKidney
_xinnervation
650 0 4 _aScience
650 0 4 _aSympathectomy
650 0 4 _aSystole
_xphysiology
650 0 4 _aTreatment Outcome
773 0 _tHipertension y riesgo vascular
_gvol. 35
_gno. 1
_gp. 42-43
856 4 0 _uhttps://doi.org/10.1016/j.hipert.2017.05.002
_zAvailable from publisher's website
999 _c27252121
_d27252121